To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
DrugBankThe DrugBank database available at the University of Alberta is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, pathway) information. The database contains nearly 4100 drug entries including >1000 FDA-approved small molecule drugs, 110 FDA-approved biotech (protein/peptide) drugs, >100 nutraceuticals and >3200 experimental drugs. Additionally, more than 15,000 protein (i.e. drug target) sequences are linked to these drug entries. Each DrugCard entry contains more than 80 data fields with half of the information being devoted to drug/chemical data and the other half devoted to drug target or protein data. Users may query DrugBank in any number of ways. It is maintained by David Wishart. See also
|
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "DrugBank". A list of authors is available in Wikipedia. |
Last viewed
- Copper: An element of surprise - - Researchers in Switzerland have developed efficient copper-functionalised dye-sensitized solar cells as an alternative to ruthenium-functionalised systems.
- Double whammy for platinum cluster - - Scientists in Canada have determined the structure of a carbonatoplatinum(IV) complex that shows an unprecedented geometry
- Urology 'Gold Journal' Publishes Successful Phase 2 Study of Innovative Topical Drug For Erectile Dysfunction -
- MIT replaces chrome coatings with safer metal alloys -
- Positive image of nanotechnology in the media - - BfR publishes analysis of nanotechnology coverage
